Edwards Lifesciences Corp. Stock
Edwards Lifesciences Corp. shows a slight decrease today, losing -€0.120 (-0.150%) compared to yesterday.
The stock is an absolute favorite of our community with 31 Buy predictions and no Sell predictions.
With a target price of 85 € there is a slightly positive potential of 9.54% for Edwards Lifesciences Corp. compared to the current price of 77.6 €.
So far the community has only identified positive things for Edwards Lifesciences Corp. stock. The most positive votes were given for criterium "Market Position".
Pros and Cons of Edwards Lifesciences Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Edwards Lifesciences Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | -0.150% | 3.994% | -6.551% | 16.046% | 4.879% | 6.975% | -20.800% |
| Veeva Systems A | 4.470% | 12.758% | 18.349% | -16.958% | 4.073% | 11.465% | -30.847% |
| Boston Scientific | -0.210% | 5.269% | 7.511% | -51.748% | -47.598% | -7.473% | 12.220% |
| Waters Corp. | 1.100% | 7.579% | 7.121% | 47.589% | 7.383% | 33.333% | 4.142% |
Comments
Edwards Lifesciences (EW) is now covered by UBS Group AG. They set a "buy" rating and a $110.00 price target on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (EW) had its price target raised by JPMorgan Chase & Co. from $100.00 to $105.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (EW) was upgraded by Leerink Partners from "market perform" to "outperform". They now have a $101.00 price target on the stock.
Show more
Ratings data for EW provided by MarketBeat